Ovarian Endometrioid Tumor — Trials

Ovarian Endometrioid Tumor — Trials · CancerIndex

Clinical trials

Registered studies

79 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–4 of 4 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05295589	Comparing Standard of Care Chemotherapy Treatment to the Combination of Copanlisib and Olaparib for Recurrent Platinum Resistant Ovarian Cancer That Has Progressed Through PARP Inhibitor Therapy	withdrawn	Phase 2	0	National Cancer Institute (NCI)NIH	1	Sep 26, 2023	clinicaltrials
NCT04510584	Maintenance Treatment With Bevacizumab and Atezolizumab for Ovarian Cancer	withdrawn	Phase 2	0	University Health Network, TorontoOTHER	1	Jun 6, 2023	clinicaltrials
NCT04611139	Pilot Trial of SP-2577 Plus Pembrolizumab in Select Gynecologic Cancers	withdrawn	Phase 1	0	HonorHealth Research InstituteOTHER	1	Mar 2, 2022	clinicaltrials
NCT01492920

Data updated 22 days agoSource updated Sep 26, 2023source: clinicaltrials